Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000286932 | SCV000343823 | benign | not specified | 2016-08-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000286932 | SCV000527694 | likely benign | not specified | 2017-10-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000470157 | SCV000561600 | benign | Charcot-Marie-Tooth disease type 4 | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173095 | SCV001336171 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002418130 | SCV002724022 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004703581 | SCV005208364 | likely benign | not provided | criteria provided, single submitter | not provided |